Results
PMID | 10632434 |
Gene Name | IL6 |
Condition | Endometriosis |
Association |
Associated |
Population size | 76 |
Population details | 66 (34 with and 32 without endometriosis, 10 oral contraceptive users undergoing tubal ligation) |
Sex | Female |
Infertility type | Female infertility |
Associated genes | VEGF, IL-6 |
Other associated phenotypes |
Endometriosis |
Fertil Steril. 2000 Jan;73(1):166-70. Mahnke, J L| Dawood, M Y| Huang, J C Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Health Science Center, Houston, USA. OBJECTIVE(S): To determine [1] vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) levels in peritoneal fluid from women with endometriosis and compare them with those from oral contraceptive (OC) users and normal cycling women and [2] any correlation between VEGF and IL-6 concentrations. DESIGN: Controlled clinical study. SETTING: University medical center. PATIENT(S): Patients undergoing laparoscopy for infertility or other benign gynecologic conditions. INTERVENTION(S): Peritoneal fluid samples were collected. MAIN OUTCOME MEASURE(S): Levels of VEGF and IL-6 in peritoneal fluid were determined. RESULT(S): Compared with normal controls or women with less severe endometriosis (implant scores of 5 or less), women with more advanced endometriosis (implant scores of 6 or more) have elevated VEGF and IL-6 levels in peritoneal fluid. Compared with normal controls, markedly suppressed IL-6 but similar VEGF levels were found in peritoneal fluid from OC users. Neither VEGF nor IL-6 varied cyclically in normal women or those with endometriosis. There was no correlation between levels of VEGF and IL-6 in peritoneal fluid. There was no correlation between implant scores and VEGF or IL-6 levels. CONCLUSION: The inflammation associated with endometriosis, through increased levels of peritoneal fluid VEGF, may promote angiogenesis for the progressive growth of endometriosis. Effective treatment of endometriosis by combination estrogen-progestin pills may involve the suppression of such inflammatory responses. Mesh Terms: Ascitic Fluid/*metabolism| Contraceptives, Oral| Endometriosis/*metabolism| Endothelial Growth Factors/*metabolism| Female| Follicular Phase| Humans| Interleukin-6/*metabolism| Luteal Phase| Lymphokines/*metabolism| Reference Values| Vascular E |